Jiangsu Kanion Pharmaceutical Co.,Ltd.

600557.SS · SHH

Market closed12.85-0.780000 (-5.72%)

Key statistics

Previous close13.63
Open13.50
Day high13.67
Day low12.85
52-week high20.20
52-week low10.69
Market cap7.28B
Volume11.06M
Average volume7.53M
P/E ratio26.08
Forward P/E
EPS0.49
Dividend yield0.00%

Market context

Why it moved

600557.SS experienced a sharp decline today likely driven by broad sector selling pressure and negative market sentiment weighing on the stock, pulling it significantly below its previous close.

What is happening

Recent company-specific developments and publisher coverage.

Mt Newswire · April 20, 2026Jiangsu Kanion Pharmaceutical Gets Greenlight for Rheumatoid Arthritis Drug Trial
Mt Newswire · February 26, 2026Jiangsu Kanion Pharmaceutical Gets Clinical Trial Nod for Heart Failure Drug
Mt Newswire · December 15, 2025Kanion Pharmaceutical Gets Approval for Traditional Chinese Drug for Asthma
Mt Newswire · December 12, 2025Jiangsu Kanion Pharmaceutical Appoints CFO
Mt Newswire · December 9, 2025Three Jiangsu Kanion Pharmaceutical Drugs Included in China's Insurance Catalog

Peers